Results 161 to 170 of about 411,749 (186)

Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart

Diabetes Care, 2003
Philippe Vague, Jean-Louis Selam, Hanne Haahr   +2 more
exaly  

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

Diabetes, Obesity and Metabolism, 2005
T Haak, W Waldhäusl, A Tiengo
exaly  

The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

Pharmaceutical Research, 2004
Peter Kurtzhals, Aage Vølund, Jan Markussen   +2 more
exaly  

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly Controlled Type 2 Diabetes

Clinical Therapeutics, 2006
Guillaume Charpentier, Athena Philis-Tsimikas, Birger Thorsteinsson   +2 more
exaly  

Insulin-detemir

Reactions Weekly
openaire   +1 more source

Insulin detemir

Reactions Weekly, 2010
openaire   +1 more source

Insulin-aspart/insulin-detemir

Reactions Weekly, 2022
openaire   +1 more source

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes

Diabetes, Obesity and Metabolism, 2013
Luigi F Meneghini, P Hollander
exaly  

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

Diabetologia, 2004
Pierre Fontaine, M A Gall
exaly  

Insulin aspart/insulin detemir

Reactions Weekly, 2021
openaire   +1 more source